Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00358 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Hajime Uno und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Medical Oncology. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Biomarker-driven trials are key for precision oncology but challenge design and analysis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
- Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
- Department of Medicine, Harvard Medical School, Boston, MA.
- Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA.
ORCID-Profile: Hajime Uno, Miki Horiguchi
Förderung
- NIGMS NIH HHS
Zitieren
APA
Uno, H., & Horiguchi, M. (2024). Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO Precision Oncology. https://doi.org/10.1200/po.24.00358
Vancouver
Uno H, Horiguchi M. Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO Precision Oncology. 2024. doi:10.1200/po.24.00358
BibTeX
@article{Uno2024,
author = {Uno, Hajime and Horiguchi, Miki},
title = {Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00358}
}
EUVIMED